Ciklopea at NEXT Pharma Summit 2025: Supporting Innovation Through Language

Ciklopea 3 weeks ago 3 min.

We are thrilled to announce that Ciklopea will be exhibiting at the NEXT Pharma Summit 2025, taking place in the stunning city of Dubrovnik.

Ciklopea at NEXT Pharma Summit 2025: Supporting Innovation Through Language
Ciklopea at NEXT Pharma Summit 2025: Supporting Innovation Through Language

Ciklopea at NEXT Pharma Summit 2025: Supporting Innovation Through Language

We are thrilled to announce that Ciklopea will be exhibiting at the NEXT Pharma Summit 2025, taking place in the stunning city of Dubrovnik. This renowned event brings together top minds and companies from the pharmaceutical and biotech sectors to explore the future of life sciences, technology, and innovation.

Representing Ciklopea at the summit will be our Chief Strategy Officer, Mladen Stojak, and Business Development Managers, Ana Meštrović and Milena Matić. Our team will be available to connect, share insights, and discuss how smart language solutions can power the global growth of pharmaceutical companies while ensuring compliance, accuracy, and cultural relevance.

At Ciklopea, we understand that in the pharma industry, every word matters. From clinical trial documentation and regulatory submissions to patient-facing content and product labeling, high-quality translation and localization are critical for safety, trust, and success in global markets.

Why meet us at NEXT Pharma Summit?
Discover how our tailored language solutions meet the strict regulatory and scientific demands of the life sciences sector
Learn about our experience with top pharma and biotech companies
Explore our workflows designed for speed, precision, and confidentiality
Discuss how AI and technology are shaping the future of medical translation

If you’re attending the event, make sure to stop by our booth or connect with us in advance to schedule a meeting. Let’s talk about how language can help your pharma business go further, faster.

See you in Dubrovnik!

Related Articles

Quarterly Business Reviews (QBRs) and KPIs in Localization: A Strategic Approach for Regulated Industries

3 months ago

In regulated industries such as pharmaceuticals, medical devices, technology, fintech, and life sciences, compliance is paramount and documentation errors can have significant regulatory consequences. Localization isn’t merely translation—it’s a critical risk management function requiring rigorous oversight. This is precisely why structured Quarterly Business Reviews (QBRs) and validated Key Performance Indicators (KPIs) have become essential governance tools for procurement professionals managing localization services.

Continue reading